BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 26272609)

  • 21. Extracellular Vesicle Activation of Latent HIV-1 Is Driven by EV-Associated c-Src and Cellular SRC-1 via the PI3K/AKT/mTOR Pathway.
    Barclay RA; Mensah GA; Cowen M; DeMarino C; Kim Y; Pinto DO; Erickson J; Kashanchi F
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32575590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates.
    Wu G; Barth RF; Yang W; Kawabata S; Zhang L; Green-Church K
    Mol Cancer Ther; 2006 Jan; 5(1):52-9. PubMed ID: 16432162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
    Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of serum extracellular vesicles as noninvasive diagnostic markers of glioma.
    Wang H; Jiang D; Li W; Xiang X; Zhao J; Yu B; Wang C; He Z; Zhu L; Yang Y
    Theranostics; 2019; 9(18):5347-5358. PubMed ID: 31410219
    [No Abstract]   [Full Text] [Related]  

  • 25. The exosomal compartment protects epidermal growth factor receptor from small molecule inhibitors.
    Hung Y; Wang YL; Lin YZ; Chiang SF; Wu WR; Wang SC
    Biochem Biophys Res Commun; 2019 Feb; 510(1):42-47. PubMed ID: 30683316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.
    Rusnak DW; Lackey K; Affleck K; Wood ER; Alligood KJ; Rhodes N; Keith BR; Murray DM; Knight WB; Mullin RJ; Gilmer TM
    Mol Cancer Ther; 2001 Dec; 1(2):85-94. PubMed ID: 12467226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib.
    Servidei T; Riccardi A; Mozzetti S; Ferlini C; Riccardi R
    Int J Cancer; 2008 Dec; 123(12):2939-49. PubMed ID: 18803287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras.
    Lee TH; Chennakrishnaiah S; Meehan B; Montermini L; Garnier D; D'Asti E; Hou W; Magnus N; Gayden T; Jabado N; Eppert K; Majewska L; Rak J
    Oncotarget; 2016 Aug; 7(32):51991-52002. PubMed ID: 27437771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glioma-Derived Extracellular Vesicles - Far More Than Local Mediators.
    Tankov S; Walker PR
    Front Immunol; 2021; 12():679954. PubMed ID: 34135908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
    Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.
    Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL
    Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.
    von Achenbach C; Weller M; Szabo E
    J Neurochem; 2018 Oct; 147(1):99-109. PubMed ID: 29953622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of Action of EGFR Tyrosine Kinase Receptor Incorporated in Extracellular Vesicles.
    Zanetti-Domingues LC; Bonner SE; Martin-Fernandez ML; Huber V
    Cells; 2020 Nov; 9(11):. PubMed ID: 33228060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome-Based Molecular Transfer Activity of Macrophage-Like Cells Involves Viability of Oral Carcinoma Cells: Size Exclusion Chromatography and Concentration Filter Method.
    Lu Y; Eguchi T; Sogawa C; Taha EA; Tran MT; Nara T; Wei P; Fukuoka S; Miyawaki T; Okamoto K
    Cells; 2021 May; 10(6):. PubMed ID: 34071980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of extracellular vesicle biogenesis in tumor cells: A possible way to reduce tumorigenesis.
    Rezaie J; Akbari A; Rahbarghazi R
    Cell Biochem Funct; 2022 Apr; 40(3):248-262. PubMed ID: 35285964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes.
    Lázaro-Ibáñez E; Sanz-Garcia A; Visakorpi T; Escobedo-Lucea C; Siljander P; Ayuso-Sacido A; Yliperttula M
    Prostate; 2014 Oct; 74(14):1379-90. PubMed ID: 25111183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
    Harding J; Burtness B
    Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor.
    Garnier D; Magnus N; Lee TH; Bentley V; Meehan B; Milsom C; Montermini L; Kislinger T; Rak J
    J Biol Chem; 2012 Dec; 287(52):43565-72. PubMed ID: 23118232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
    Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
    Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.